FDA panel backs prescribing opioid overdose reversal drug along with painkillers
Source: Reuters
HEALTH NEWS DECEMBER 18, 2018 / 3:34 PM / UPDATED 17 HOURS AGO
FDA panel backs prescribing opioid overdose reversal drug along with painkillers
Saumya Joseph, Manas Mishra
3 MIN READ
(Reuters) - An advisory panel to the U.S. Food and Drug Administration on Tuesday recommended prescribing the opioid overdose reversal drug, naloxone, along with addictive painkillers.
The panel, which concluded a two-day discussion on ways to make the potentially life-saving drug readily available, voted 12-11 in favor of labeling changes for opioids that recommend co-prescribing the overdose antidote.
The recommendation of the panel underscores concerns about the growing opioid overdose epidemic that claimed the lives of more than 49,000 Americans last year.
The prescription of naloxone could facilitate a healthy dialogue between patients and the healthcare provider, Maryann Amirshahi, a panel member who voted in favor, said.
-snip-
Read more:
https://www.reuters.com/article/us-usa-opioids-naloxone/fda-panel-backs-prescribing-opioid-overdose-reversal-drug-along-with-painkillers-idUSKBN1OH2CA